Andrej Pavlović scouting report: the Karaburma jewel whose value quintupled in a season
| Mevki | Centre-Back / DM |
|---|---|
| Kulüp | OFK Beograd |
| Uyruk | Serbia |
| Yaş | 19 |
| Doğum | 29.07.2007 |
| Boy | 1.90 m |
| Ayak | Right |
| Piyasa Değeri | €3.5M |
| Sözleşme | 31.12.2027 ⚠ |
| Rol | Modern Centre-Back ⭐ |
Overview
Andrej Pavlović, born 29 July 2007 in Belgrade, is a 1.90 m right-footed centre-back — the OFK academy’s jewel. 2025-26 was his first professional season: 26 Superliga games, with his recorded value climbing from ~€738K to €3.5M — the squad peak shared with Cvetković. Secondary role: the No.6; an 8-9 yellow volume traces aggressive front-foot defending.
The transfer front is concrete: Famalicão bid €800K officially; OFK rejected it and asks a minimum €2M. Serbia U18-U19 shirts (6 U19 caps). The press calls him “one of OFK’s pillars”.
The math is interesting: the contract ends 31.12.2027 — short — and the €2M ask sits below the €3.5M record, an equation leaning the buyer’s way.
Data and Assessment
| İstatistik | Değer | Persentil |
|---|---|---|
| Apps | 26 | — |
| Minutes | 1326 | — |
| Assists | 1 | — |
| Yellows | 8 | — |
| U19 caps | 6 | — |
| Strengths | Development Areas |
|---|---|
| 26 first-season games at 18 — early trust | 8-9 yellows — contact-dose calibration |
| 1.90 m + a No.6 outlet — a modern profile | A single-season sample |
| The ask (€2M) below the recorded value | No international exam above U19 yet |
Verdict
The value curve, the rejected bid and the short contract point the same way; the club's €2M ask against a €3.5M record defines a window in the buyer's favour.
A buyer moving at €2-2.5M this winter closes the file before summer competition multiplies the price.
FAQ
Who is Andrej Pavlović?
A centre-back born 29 July 2007 in Belgrade; 26 Superliga games in his first professional season at OFK.
Any transfer interest?
Famalicão bid €800K officially; OFK rejected it, asking a minimum €2M.
Sources
GEGEN SCORE blends technical (20%), tactical (20%), mental (20%), physical (15%), potential (15%) and risk (10%, inverse-weighted) components into one editorial rating; it is a comparison tool, not a transfer decision by itself. Bio data verified against independent open sources. Last updated: 27 July 2026.